A Case for the Use of Combined Hormonal Therapy for Aggressive Angiomyxoma: Complete Response to Goserelin and Letrozole Following Incomplete Surgical Resection
We report on the use of combined hormonal therapy with a gonadotropin releasing hormone antagonist and aromatase inhibitor in pelvic aggressive angiomyxoma, with a complete response.
Authors
- Peter Grimison (ORCID: https://orcid.org/0000-0002-2653-1657)
- Annabelle Farnsworth (ORCID: https://orcid.org/0000-0002-2358-4972)
- Michael J. Solomon (ORCID: https://orcid.org/0000-0002-5602-6045)
- Florian Honeyball (ORCID: https://orcid.org/0000-0001-9624-0807)
- George Mallat (ORCID: https://orcid.org/0000-0003-0375-4417)
Institutions
- The University of Sydney (AU)
- NSW Department of Education (AU)
- Royal Prince Alfred Hospital (AU)
- Chris O’Brien Lifehouse (AU)
- Dubbo Hospital (AU)
- Douglass Hanly Moir Pathology (AU)
- The University of Notre Dame Australia (AU)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/ccr3.70848
- Primary Topic
- Urologic and reproductive health conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Sydney